Industry News
After Stem Cell Transplant For Multiple Myeloma Patients, Lenalidomide Prolongs Disease Control
May 16, 2012
Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid®, following a stem cell transplant, according to a study co-authored by a physician with the Oregon Health & Science University Knight Cancer Institute... Read More
Apigenin Slowed Progression Of Breast Cancer Accelerated By Hormone Replacement Therapy
May 16, 2012
Apigenin, a natural substance found in grocery store produce aisles, shows promise as a non-toxic treatment for an aggressive form of human breast cancer, following a new study at the University of Missouri. MU researchers found apigenin shrank a type of breast cancer tumor that is stimulated by progestin, a synthetic hormone given to women to ease symptoms related to menopause... Read More
Marker To Identify, Attack Breast Cancer Stem Cells
May 16, 2012
Breast cancer stem cells wear a cell surface protein that is part nametag and part bull's eye, identifying them as potent tumor-generating cells and flagging their vulnerability to a drug, researchers at The University of Texas MD Anderson Cancer Center report online in Journal of Clinical Investigation... Read More
In Outcome Of Prostate Cancer Surgery, Higher Hospital Volume More Important Than Surgeon Experience
May 16, 2012
Older, sicker, high-risk patients who undergo one of the most common treatments for prostate cancer get better results in larger, busier hospitals, according to new research by Henry Ford Hospital. In such cases, the same research showed the experience level of the surgeon doing the procedure mattered somewhat less than the hospital setting... Read More
In Outcome Of Prostate Cancer Surgery, Higher Hospital Volume More Important Than Surgeon Experience
May 16, 2012
Older, sicker, high-risk patients who undergo one of the most common treatments for prostate cancer get better results in larger, busier hospitals, according to new research by Henry Ford Hospital. In such cases, the same research showed the experience level of the surgeon doing the procedure mattered somewhat less than the hospital setting... Read More
Clinical Guidance Remains Non-Specific For Drugs To Reduce Bone Cancer Damage
May 16, 2012
Bone cancer-related fractures and pain can be reduced by drug treatment, but no one drug is superior, according to a review published in The Cochrane Library. Researchers undertook a systematic review of the current evidence on bisphosphonate drugs, which are used to prevent bone damage in multiple myeloma... Read More
News From The Journal Of Clinical Investigation: May 15, 2012
May 16, 2012
DEVELOPMENT Hope for new treatment options for the rare disease Beare-Stevenson syndrome Beare-Stevenson cutis gyrata syndrome is an extremely rare genetic disease that causes serious physical problems affecting the skin and skull... Read More
Revlimid (Lenalidomide) For Myeloma - Phase III Study Findings
May 16, 2012
An evaluation of lenalidomide's (Revlimid) long-term 'maintenance' efficacy for patients with multiple myeloma has demonstrated considerable improvements from the time to progression and overall survival for those suffering from this often-fatal form of hematologic cancer. The May 10 issue of the New England Journal of Medicine reports that Dr. Philip L... Read More
Eye Cancer Tumors Likely To Spread Can Be Identified By Genetic Test
May 16, 2012
Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver... Read More
Discovery Of New Gene Mutations Leads To Breakthrough In Understanding The Cause Of Bile Duct Cancer
May 16, 2012
A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop. Their discovery is published online in Nature Genetics... Read More
Previous Page Next Page